Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

APPOINTMENTS AND ADVANCEMENTS

March 23, 1992

THREE PATENTS COVER NEUROGEN TECHNOLOGY

March 23, 1992

POWERFUL NEW DRUG DISCOVERY TECHNOLOGY

March 20, 1992

LAWMAKER SAYS ADMINISTRATION PUSHING FDA

March 20, 1992

VIMRX CLEARED TO RESUME AIDS TRIALS

March 20, 1992

CALGENE SELLS 2.3M SHARES

March 20, 1992

ENGLISH COMPANY ENTERS HEPATITIS B MARKET

March 20, 1992

WARRANT EXERCISE RAISES $15.5M

March 20, 1992

DEPRENYL RESEARCH UNHAPPY WITH ANALYST

March 20, 1992

FDA APPROVES QUIDEL OVULATION TEST

March 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...